Lensar (LNSR) Capital Expenditures (QoQ) (2020 - 2025)
Lensar (LNSR) Capital Expenditures (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.69 Bn | 175.40 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn |
| 3 | Medtronic | 108.07 Bn | 98.85 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.93 Bn | 66.47 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.11 Bn | 44.44 Bn | 1.29 Bn |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.89 Bn | 25.60 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.42 Bn | - |
| 9 | Koninklijke Philips | 24.05 Bn | 20.92 Bn | 2.07 Bn |
| 10 | Lensar | 65.49 Mn | 54.39 Mn | 6.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1,183.33% |
| Mar 31, 2025 | 100.00% |
| Dec 31, 2024 | -85.00% |
| Sep 30, 2024 | -25.93% |
| Jun 30, 2024 | -74.53% |
| Mar 31, 2024 | 135.56% |
| Dec 31, 2023 | 2,150.00% |
| Sep 30, 2023 | -98.90% |
| Jun 30, 2023 | 2,162.50% |
| Mar 31, 2023 | -85.96% |
| Dec 31, 2022 | 2,750.00% |
| Sep 30, 2022 | -80.00% |
| Jun 30, 2022 | -78.26% |
| Mar 31, 2022 | -70.51% |
| Dec 31, 2021 | 6.12% |
| Sep 30, 2021 | 333.33% |
| Jun 30, 2021 | -155.26% |
| Mar 31, 2021 | 8.57% |
| Dec 31, 2020 | 1,650.00% |
| Sep 30, 2020 | -96.05% |